Scientists are researching if a drug that’s being tested to treat a skin condition can also help keep COVID-19 patients off ventilators. The drug, labeled as EDP1815, was being tested on psoriasis patients, but Dr. Reynold Panettieri, vice chancellor for translational medicine and science at Rutgers University, said it will now be tested on coronavirus patients who have pneumonia and inflammation of the lungs. To read the full article.
Recent Posts
- Clinical Trials Day 2026 is May 20th – Submit an Abstract by February 13th
- Clinical trial in N.J. gives patients with incurable cancer a new chance at life.
- Entrepreneurship Lessons Coming to Introductory Engineering Courses.
- Scientists Develop Plastics That Can Break Down, Tackling Pollution.
- NJACTS Community Engagement Core COVID-19 Resources
Categories
- Community (2,430)
- Covid (996)
- CTO Events (6)
- News (3,077)
- Pilots (21)